市場調査レポート
商品コード
1345181

低侵襲脊椎装置市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業など)、2023年最新版

Minimal Invasive Spinal Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
低侵襲脊椎装置市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業など)、2023年最新版
出版日: 2023年08月21日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

最小侵襲脊椎(MIS)固定術は、カニューレ型スクリューや非カニューレ型スクリューなどのデバイスを使用して椎骨や関節を安定させるために行われます。

当レポートでは、低侵襲脊椎装置市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

  • 低侵襲脊椎装置の概要

第3章 開発中の製品

  • 低侵襲脊椎装置- 開発段階別パイプライン製品
  • 低侵襲脊椎装置- セグメント別パイプライン製品
  • 低侵襲脊椎装置- 地域別パイプライン製品
  • 低侵襲脊椎装置- 規制経路別パイプライン製品
  • 低侵襲脊椎装置- 推定承認日別パイプライン製品
  • 低侵襲脊椎装置- 進行中の臨床試験

第4章 低侵襲脊椎装置- 企業が開発中のパイプライン製品

  • 低侵襲脊椎装置企業- 開発段階別パイプライン製品
  • 低侵襲脊椎装置- 開発段階別パイプライン製品

第5章 低侵襲脊椎装置の企業と製品の概要

第6章 低侵襲脊椎装置- 最近の開発

  • 2023年7月5日:Inspired Spineがドイツで第3回国際ラボを主催し、OLLIFとTrident SIの共同融合手順を紹介
  • 2023年5月23日:Aurora Spineは、2023会計年度第1四半期財務結果のリリースと電話会議を予定
  • 2023年4月26日:Aurora Spineは、2022年度第4四半期財務結果のリリースと電話会議を予定
  • 2023年2月16日:Lazuriteが医師を医療諮問委員会に任命
  • 2022年11月21日:Aurora Spineが2022会計年度第3四半期の財務結果を発表
  • 2022年10月12日:Aurora Spine Corporationが北米脊椎学会年次総会に出席

第7章 付録

  • 調査手法
  • GlobalDataについて
  • お問合せ
  • 免責事項
図表

List of Tables

List of Tables

  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimal Invasive Spinal Devices - Ongoing Clinical Trials
  • Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimal Invasive Spinal Devices - Ongoing Clinical Trials
目次
Product Code: GDME1608EPD

Abstract

GlobalData's Medical Devices sector report, "Minimal Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Minimal Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Minimal Invasive Spinal Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Minimal Invasive Spinal Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Minimal Invasive Spinal Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Minimal Invasive Spinal Devices Overview

3 Products under Development

  • 3.1 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • 3.2 Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • 3.3 Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • 3.4 Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • 3.5 Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Minimal Invasive Spinal Devices - Ongoing Clinical Trials

4 Minimal Invasive Spinal Devices - Pipeline Products under Development by Companies

  • 4.1 Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimal Invasive Spinal Devices Companies and Product Overview

6 Minimal Invasive Spinal Devices- Recent Developments

  • 6.1 Jul 05, 2023: Inspired Spine Hosts Third International Lab in Germany, Showcasing OLLIF and Trident SI Joint Fusion Procedures
  • 6.2 May 23, 2023: Aurora Spine schedules release of Q1 fiscal year 2023 financial results and conference call
  • 6.3 Apr 26, 2023: Aurora Spine schedules release of Q4 and fiscal year 2022 financial results and conference call
  • 6.4 Feb 16, 2023: Lazurite Names Physicians to Medical Advisory Board
  • 6.5 Nov 21, 2022: Aurora Spine Announces Third Quarter Fiscal 2022 Financial Results
  • 6.6 Oct 12, 2022: Aurora Spine Corporation to Attend the North American Spine Society Annual Meeting

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer